Distribution of micafungin in the tissue fluids of patients with invasive fungal infections

Journal of Infection and Chemotherapy

Volumn 17, Issue 5, 2011, Pages 731-734

  Yamada, Noriaki ^a   Kumada, Keisuke ^a   Kishino, Satoshi ^b   Mochizuki, Nobuo ^b   Ohno, Keiko ^b   Ogura, Shinji ^a  

^a GIFU UNIVERSITY   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Ascites; Cerebrospinal fluid; Echinocandin antifungal; Micafungin; Pleural effusions

Indexed keywords

MICAFUNGIN;

ADULT; AGED; ARTICLE; ASCITES; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TISSUE LEVEL; FEMALE; FUNGEMIA; HUMAN; HUMAN TISSUE; MALE; MINIMUM INHIBITORY CONCENTRATION; PLEURA EFFUSION; SYSTEMIC MYCOSIS; WOUND;

EID: 84855448583     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-011-0240-3     Document Type: Article

References (14)

1. Hatano K, Morishita Y, Nakai T, Ikeda F. Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus. J Antibiot (Tokyo). 2002;55:219-22. (Pubitemid 34285463)
2. Tawara S, Ikeda F, Maki K, Morishita Y, Otomo K, Teratani N, et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother. 2000;44:57-62. (Pubitemid 30010672)
3. Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother. 2004;53:283-9. (Pubitemid 38239963)
4. Cross SA, Scott LJ. Micafungin: A review of its use in adults for treatment of invasive and oesophageal candidasis and prophylaxis against Candida infections. Drugs. 2008;68:2225-55.
5. de Wet NT, Bester AJ, Viljoen JJ, Filho F, Suleiman JM, Ticona E, et al. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. Aliment Pharmacol Ther. 2005;21:899-907. (Pubitemid 40477250)
6. Tamura K, Urabe A, Yoshida M, Kanamaru A, Kodera Y, Okamoto S, et al. Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders. Leuk Lymphoma. 2009; 50:92-100.
7. Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: A phase III randomised double-blind trial. Lancet. 2007;369:1519-27. (Pubitemid 46670281)
8. Groll AH, Mickiene D, Petraitis V, Petraitiene R, Ibrahim KH, Piscitelli SC, et al. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits. Antimicrob Agents Chemother. 2001; 45:3322-7. (Pubitemid 33107841)
9. Yamato Y, Kaneko H, Yamasaki S, Fujiwara T, Katashima M, IshibashiK, et al. Distribution and excretion after intravenous dosing of [14C]micafingin to rats. Jpn J Chemother. 2002;50(suppl 1): 80-7. (Pubitemid 36033013)
10. Niwa T, Yokota Y, Tokunaga A, Yamato Y, Kagayama A, Fujiwara T, et al. Tissue distribution after intravenous dosing of micafungin, an antifungal drug, to rats. Biol Pharm Bull. 2004; 27:1154-6. (Pubitemid 41701780)
11. Suzuki T, Uno T, Chen G, Ohashi Y. Ocular distribution of intravenously administered micafungin in rabbits. J Infect Chemother. 2008;14:204-7. (Pubitemid 351875926)
12. Yamato Y, Kaneko H, Tanimoto K, Katashima M, Ishibashi K, Kawamura A, et al. Simultaneous determination of antifungal drug, micafungin, and its two active metabolites in human plasma using high-performance liquid chromatography with fluorescence detection. Jpn J Chemother. 2002;50(suppl 1):68-73. (Pubitemid 36033011)
13. Azuma J, Nakahara K, Kagayama A, Okuma T, Kawamura A, Mukai T. Pharmacokinetic study of micafungin. Jpn J Chemother. 2002;50(suppl 1):155-84. (Pubitemid 36033018)
14. Okugawa S, Ota Y, Tatsuno K, Tsukada K, Kishino S, Koike K. A case of invasive central nervous system aspergillosis treated with micafungin with monitoring of micafungin concentrations in the cerebrospinal fluid. Scand J Infect Dis. 2007;39:344-6. (Pubitemid 46567386)